Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-16 |
filingDate |
2007-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2011-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EA-201000771-A1 |
titleOfInvention |
TETRACYCLIC DIPIRANOCUMARINE CONNECTIONS WITH ACTIVITY AGAINST HIV AND MYCOBACTERIUM TUBERCULOSIS |
abstract |
The present invention relates to tetracycline dipiranocoumarin compounds of the general formula (I), wherein the substituents are as defined herein. These compounds exhibit dual biological activity against infection of the human immunodeficiency virus type 1 (HIV-1) and against Mycobacterium tuberculosis (TB) infection. |
priorityDate |
2007-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |